These two cases further suggest that NRAS mutations may also be present in the spectrum of mosaic disorders including ECCL and OES in addition to the more frequently reported FGFR-1 and KRAS genes. This evidence concerns the gene KRAS and encephalocraniocutaneous lipomatosis.